✓ Purity · pass✓ Lab-verifiedShop-provided sample
Semaglutide / Tirzepatide / Retatrutide × ezpeptides.com — lab test, April 2026
Tested · submitted by Peptigrity Team Member 02PEPTIGRITY TEAM
Sample source: shop-provided. The shop chose and sent this vial. Samples bought at retail by a member carry more weight.How we weigh evidence →
HPLC Purity
99.9%
✓ Excellent purity only
Independently confirmed on the lab’s portal✓ Extra check
COA 147745 matches freedomdiagnosticstesting.com's public record. So this test doesn't rest on our review alone — the lab confirms it too.
Lookup code
1JMGHSMC5RVELook it up on freedomdiagnosticstesting.com ↗Checked Apr 14, 2026
Test results
4 data points
Purity
99.9%
Endotoxins
Not tested
Heavy metals
Not tested
Stated qty
Not provided
Tested qty
Not provided
Batch / Lot
EZP-3P1004012026-02
COA number
147745
Container
Transparent Purple or Purple/Green
Tested by
freedomdiagnosticstesting.comView profile →
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Verification trail
| Report number | 147745 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 15 Jul 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | freedomdiagnosticstesting.com's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Semaglutide / Tirzepatide / Retatrutide from ezpeptides.com, performed by freedomdiagnosticstesting.com on April 14, 2026. Reported purity: 99.9%. Batch EZP-3P1004012026-02. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Original document
Issued by freedomdiagnosticstesting.com · Apr 14, 2026 · Batch EZP-3P1004012026-02
♡ Likes · 0
No comments yet. Sign in to discuss this test →
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion